Arcutis Announces Additions to its Investor Relations and Communications Team
02 août 2021 16h05 HE
|
Arcutis Biotherapeutics, Inc.
Eric McIntyre joins as Head of Investor RelationsAmanda Sheldon joins as Head of Corporate Communications WESTLAKE VILLAGE, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics,...
Arcutis Advances Science of Psoriasis Drug Development with New Precision Method for Measuring Mild-to-Moderate Psoriasis
21 juil. 2021 08h00 HE
|
Arcutis Biotherapeutics, Inc.
The majority of patients with psoriasis have mild or moderate levels of diseaseThe new method, PASI-high discrimination (PASI-HD), is designed for use in clinical trials evaluating novel topical...
Arcutis Announces First Patient Enrolled in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-154) as a Potential Treatment for Seborrheic Dermatitis
12 juil. 2021 08h00 HE
|
Arcutis Biotherapeutics, Inc.
Topical roflumilast potential “Best-in-Class” topical PDE4 inhibitorSeborrheic dermatitis affects 10 million patients in the U.S.Potential first new topical treatment for seborrheic dermatitis in...
Arcutis Provides Update on Phase 2a Clinical Trial Evaluating ARQ-252 Cream as a Potential Treatment for Vitiligo
01 juil. 2021 06h00 HE
|
Arcutis Biotherapeutics, Inc.
Formulation-related observations from ARQ-252 trial in chronic hand eczema informed early termination of Phase 2a ARQ-252 trial in vitiligoCompany progressing new formulation with goal of greater drug...
Greg Sukay Joins Arcutis as Vice President of Manufacturing and Process Technologies
23 juin 2021 08h00 HE
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments...
Arcutis Announces Appointment of Sue-Jean Lin to Board of Directors
09 juin 2021 16h01 HE
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments...
Rajvir Madan Joins Arcutis as Chief Digital and Information Officer
01 juin 2021 07h30 HE
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments...
Arcutis Biotherapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
11 nov. 2020 16h05 HE
|
Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments...